Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Insmed Inc. | 46 | 0 | 6 | 0 | €68.50 | €77.41 | 13.013% |
Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | €66.00 | €84.73 | 28.376% |
Cytokinetics Inc. | 30 | 1 | 1 | 0 | €50.00 | €84.22 | 68.446% |
R1 RCM Inc. | 23 | 0 | 0 | 0 | €12.40 | €17.21 | 38.811% |
Addus Homecare Corp. | 23 | 1 | 4 | 0 | €122.00 | €122.73 | 0.597% |
EyePoint Pharmaceuticals Inc. | 21 | 1 | 2 | 0 | €8.21 | €27.91 | 239.903% |
TG Therapeutics Inc. | 20 | 1 | 2 | 0 | €20.99 | €31.12 | 48.278% |
Krystal Biotech | 19 | 0 | 3 | 0 | €183.50 | €186.59 | 1.684% |
G1 Therapeutics | 19 | 1 | 0 | 0 | €6.41 | €11.09 | 73.133% |
Esperion Therapeutis.Inc. | 18 | 1 | 4 | 0 | €1.53 | €9.27 | 508.052% |
Corcept Therapeutics Inc. | 17 | 0 | 2 | 0 | €31.00 | €36.87 | 18.929% |
Verastem Inc. | 16 | 0 | 4 | 0 | €2.18 | €16.20 | 643.271% |
Geron Corp. | 16 | 0 | 1 | 0 | €4.06 | €5.54 | 36.252% |
Intellia Therapeutics Inc | 16 | 1 | 2 | 0 | €20.11 | €60.12 | 198.948% |
Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €44.80 | €46.51 | 3.806% |
Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | €18.34 | €26.64 | 45.293% |
MacroGenics Inc. | 14 | 0 | 3 | 0 | €3.06 | €12.31 | 301.599% |
Prothena Corp. plc | 13 | 0 | 2 | 0 | €19.10 | €78.70 | 312.045% |
Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
Staar Surgical Co. | 13 | 1 | 1 | 0 | €29.30 | €47.59 | 62.435% |
Adverum Biotechnologies Inc. | 11 | 0 | 2 | 0 | €1.38 | €23.35 | 1591.667% |
AnaptysBio Inc | 12 | 1 | 3 | 0 | €32.60 | €48.09 | 47.507% |
Ocular Therapeutix Inc. | 15 | 4 | 1 | 0 | €8.09 | €13.09 | 61.759% |
Pro-Dex Inc. | 10 | 0 | 0 | 0 | €18.40 | - | - |
Heron Therapeutics Inc. | 11 | 1 | 1 | 0 | €1.78 | €4.63 | 160.022% |